Premier’s statement on business restrictions – impacts for businesses
4 August 2020 Release date 3 August 2020 Yesterday Daniel Andrews, Premier of Victoria announced a series of business restrictions. These are in direct response to Victoria’s move to Stage 4 Restrictions in combating COVID-19 transmission. Read the…
AHHA position paper: the effective and sustainable adoption of virtual health care
4 August 2020 On 24 July 2020, The Australian Healthcare and Hospitals Association (AHHA) published a position paper as a supplement to Healthy people, Healthy systems: strategies for outcomes-focused and value-based healthcare entitled “The effective and sustainable adoption…
Starpharma DEP® docetaxel and gemcitabine combination trial commences
4 August 2020 Release date 30 July 2020 Starpharma today announced that it has commenced its DEP® docetaxel + gemcitabine combination study for patients with advanced cancers, including pancreatic cancer. Recruitment into the study has commenced at the…
Cynata Completes Phase 1 GvHD Clinical Trial Follow-up with Positive Results
4 August 2020 Release date 30 July 2020 Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, has today announced positive results from the two-year follow-up of patients enrolled in the Phase 1 clinical trial of…
Medical research grant recipients announced, including COVID-19 research fund grants
4 August 2020 The Victorian Government is backing cutting-edge medical research projects to better understand, prevent and treat coronavirus. Seven projects will benefit from the government’s $5.5 million COVID-19 Research Fund, which will support continued jobs growth in a sector…
EY 2020 Australian Insurtech Report: Partnering to Deliver Value at Scale
4 August 2020 The EY 2020 Australian insurtech ecosystem report shows insurtechs, insurers and service providers agree that the industry is driving value through insurtech, but there are several areas ripe for innovation. EY’s previous two reports found…
Stem cell project aims to better understand impact of COVID-19 on different organs
4 August 2020 Release date 30 July 2020 Researchers at the Murdoch Children’s Research Institute (MCRI), with other Melbourne-based partners, will use human stem cells to better understand the effects of COVID-19 on different organs after being…
AustralaSian COVID-19 Trial (ASCOT) removes hydroxychloroquine and lopinavir/ritonavir arms of the trial
4 August 2020 Release date: 30 July 2020 Following reports that hydroxychloroquine and lopinavir/ritonavir are not effective in reducing mortality from COVID-19, the AustralaSian COVID-19 Trial (ASCOT) Steering Committee has also made the decision to remove the hydroxychloroquine and lopinavir/ritonavir…
AAMRI’s budget priority: secure the future of Australia’s next generation of talent
3 August 2020 Australian medical research institutes are raising the alarm about the precarious position facing our earlier-career scientists. In their 2020 Budget Submission the Association of Australian Medical Research Institutes (AAMRI) has outlined the risk of losing the next…
ARC Future Fellows pave the way for Australian research
4 August 2020 Release date 29 July 2020 The Australian Research Council (ARC) will support 100 mid-career researchers to grow knowledge and innovation for the benefit of the Australian community by undertaking high quality research. ARC Chief Executive…
Navi Medical Technologies Secure City of Melbourne Small Business Grant
30 July 2020 The City of Melbourne has helped hundreds of innovators and entrepreneurs start up or expand their businesses since 1996. They have also encouraged dozens of businesses to enter overseas markets and supported member-based organisations to…
Dimerix’s DMX-200 posts strong results in kidney disease trial
29 July 2020 Melbourne-based, clinical-stage biopharmaceutical company Dimerix has reported excellent results from the clinical trial of its drug candidate DMX-200, which is aimed at a rare kidney disease called focal segmental glomerulosclerosis, or FSGS. FSGS is caused…
